baber/WOPTO huggingface dataset:
Patent AU-3676389-A (AU)
Title: Preparation of oxyalkylated, carboxyl-containing polymers
Inventor: DENZINGER WALTER
IPC: C08F8/14
Filed: 1989-06-23
Abstract: Oxyalkylated, carboxyl-containing polymers are prepared by reacting (A) a polymer which contains one or more monoethylenically unsaturated C3-C6-carboxylic acids as copolymerized units with (B) an alkylene oxide in an aqueous medium at not more than 120 DEG  C. by a process in which the reaction is started at a pH of from 5.0 to 5.9 and is ended after a pH of from 5.5 to 8.5 has been reached. As a result of monitoring of the pH, the selectivity of the addition reaction of alkylene oxides with the polymers (A) is substantially improved compared with known processes.
Patent AU-3850399-A (AU)
Title: Gene recombinant antibodies
Inventor: SHITARA KENYA
IPC: C07K16/28
Filed: 1999-05-20
Abstract: The present invention relates to a gene recombinant antibody which specifically reacts with human VEGF receptor Flt-1. Also, the present invention relates to a gene recombinant anti-human VEGF receptor Flt-1 antibody having an activity which neutralizes human Flt-1. Furthermore, it provides a method, a diagnostic agent and a therapeutic agent for treating diseases in which their morbid states progress by abnormal angiogenesis, such as proliferation or metastasis of solid tumors, arthritis in chronic rheumatoid arthritis, diabetic retinopathy, retinopathy of prematurity, psoriasis, and the like.
Patent AU-3858695-A (AU)
Title: Serial linked interconnect for summation of multiple waveforms on a common channel
Inventor: LEVIN JEFFREY A
IPC: H04B7/005
Filed: 1995-09-29
Abstract: A modulator for a spread spectrum telecommunication system not only receives local data and processes it, but also receives input data from one or more other modulators, sums the input data with the local data, and provides the sum as data for a subsequent modulator or as final output for a transmit power amplifier. The modulator includes an input block and an output block and, depending on a control data signal, input data will be summed with the internally generated local data of the modulator before being provided to the output block. The output data can include parity data. The parity data can be used to check for faults such as might be introduced, for example, by a faulty connection or broken hard-wired interconnect. If an error is detected, the summation function of the transmit modulator can be automatically disabled.
Patent AU-3883399-A (AU)
Title: Photosensitive paste, substrate for plasma display panel using the same, and method of production of the substrate
Inventor: YOKOYAMA CHIKAFUMI
IPC: H01J11/22
Filed: 1999-05-05
Abstract: To provide a photosensitive paste (30), which makes it possible to easily form a rib (16) having improved quality, in the production of a substrate (12) for PDP (10). The photosensitive paste (30) is composed of a powder of ceramics, and a photocurable binder that includes a silane coupling agent having a functional group, which is polymerized by radiation.
Patent AU-3938395-A (AU)
Title: Flame retardant polyamide composition
Inventor: KEIJZER AUGUSTINUS EUGENE HENK
IPC: C08K5/3492
Filed: 1995-11-23
Abstract: A process for the preparation of a melamine condensation product comprising the step of heating a starting material comprising melamine or a melamine salt in the presence of: (i) at least one organic acid, (ii) at least one ammonia or melamine salt of the organic acid, or (iii) a mixture of (i) and (ii), under reaction conditions effective for the formation of the melamine condensation product. The melamine condensation product with a residual condensation agent content of less than 1 wt. % is useful in a moldable polymer composition possessing flame-retardant properties.
Patent AU-3943397-A (AU)
Title: New antiviral lipopeptides, and a method of inactivating lipid-enveloped viruses using lipopeptides
Inventor: VOLLENBROICH DIRK
IPC: C07K7/06
Filed: 1997-08-11
Abstract: The invention relates to an extraordinarily efficient method of inactivating lipid-enveloped viruses, such as herpes or retroviruses, in biological or biotechnological-particularly pharmaceutical-products, as well as in cell cultures by adding a cyclic lipopeptide or a mixture of lipopeptides or salts or esters thereof at specific concentrations. Lipopeptides were found to have a surprisingly high inactivation potential for lipid-enveloped viruses and in addition, they offer the advantage of an exceedingly low in vivo toxicity, so that the step of removing the inactivating agent from pharmaceutical products or cell cultures can be omitted. The invention is also directed to new antiviral lipopeptides which belong to the surfactins.
Patent AU-4030099-A (AU)
Title: A box for storing a storage medium
IPC: G11B33/04
Filed: 1999-05-27
Abstract: A box for storing a storage medium, comprising two parallel walls. A first one of the walls has an outer surface with protruding studs, and a second wall has an outer surface with cavities for receiving the studs on another similar box. The studs and cavities are provided in respective rows allowing two or more boxes to be stacked either aligned or shifted, and a row of several boxes shifted relative to each other is self supported and can stand on a tabletop without any support.
Patent AU-4098201-A (AU)
Title: Method for diagnosing efficacy of xenotypic antibody therapy
Inventor: NOUJAIM ANTOINE
IPC: G01N33/68
Filed: 2001-02-08
Abstract: The invention provides methods for diagnosing the efficacy of a patient to xenotypic antibody therapy which include (1) measuring the level of an antibody produced by a patient that specifically binds to a a xenotypic antibody after administration of the xenotypic antibody to the patient; (2) measuring the level of an anti-idiotype antibody produced by a patient that specifically binds to a a xenotypic antibody after administration of the xenotypic antibody to the patient; (3) measuring the level of an antibody produced by a patient that specifically binds to a target antigen of a xenotypic antibody after administration of a xenotypic antibody to the patient; and (4) measuring the level of a T cell response produced by a patient to a target antigen of the xenotypic antibody after administration of a xenotypic antibody to the patient. In the methods of the invention, an increase in the level of antibody or T cell response produced by the patient after the administration of the xenotypic antibody relative to the level antibody or T cell response produced by the patient prior to the administration of the xenotypic antibody is indicative of a favorable diagnosis of efficacy.
Patent AU-4156185-A (AU)
Title: Marek,s disease vaccine
Inventor: FOPPE DE BOER GERBEN
IPC: A61K39/255
Filed: 1985-03-27
Abstract: The invention relates to a highly immunogenic virus preparation derived by attenuation employing serial passages in avian cell cultures and six plaque purification steps from a Marek's disease virus strain, belonging to Avian Herpesvirus serotype-1. The original virus strain MDV CVI-988 was recovered from a healthy chicken (Avian Disease 16:108-125,1972).The live purified Marek's disease vaccine so obtained is innocuous for specific pathogen free Rhode Island Red chickens which are highly susceptible for development of Marek's disease tumours. The monovalent virus preparation, according to the invention, demonstrated in comparison with Marek's disease vaccines based on the same strain, currently in use at a lower cell passage level, an improved protective efficacy against challenge infection by two representatives of virulent Marek's disease virus.The monovalent virus preparation, according to the invention, provided significantly better protection than current MDV CVI-988 vaccine to challenge infection with a representative of the group of newly emerging very virulent strains of Marek's disease virus, MDV RB/1B. The monovalent virus strains of Marek's disease virus, MDV RB/1B. The monovalent virus preparation, according to the invention, provided significantly better protection than is HVT FC126 vaccine to challenge infection with another representative of the group of very virulent MD viruses, MDV Tun.
Patent AU-4445899-A (AU)
Title: Method of managing a queue of digital cells
Inventor: FRENE PATRICK
IPC: H04L47/56
Filed: 1999-08-12
Abstract: A method for managing a queue of cells received from a plurality of sources, wherein the last cell received is stored at a receive address in a buffer, and a time stamp is established for the last cell received that represents the theoretical time it is to leave the queue. The receive address is inserted into a programmer at a location identified by the time stamp of the last cell received, and an occupancy bit associated with the time stamp is set to an active state. The first cell(s) to leave the queue from the first active occupancy bit following that of the cell that has just left the queue is determined, with the occupancy bits being classified in increasing order of the associated time stamps, and the occupancy bit of the first cell is set to an inactive state when it leaves the queue.
Patent AU-4531196-A (AU)
Title: Process for dividing glass panes into sections
Inventor: LISEC PETER
IPC: C03B33/02
Filed: 1996-01-17
Abstract: PCT No. PCT/AT96/00004 Sec. 371 Date Jul. 8, 1997 Sec. 102(e) Date Jul. 8, 1997 PCT Filed Jan. 17, 1996 PCT Pub. No. WO96/22948 PCT Pub. Date Aug. 1, 1996Lines are scribed on glass panes in accordance with the sections to be produced and the glass panes are then broken into sections susbtantially in a vertical position. A device suitable therefor comprises a station (2) for scribing the glass panes (1) with a substantially vertical supporting surface (25) and a conveyor (13) at its lower edge. Adjoining the station (2) is a first breaking station (3) and second one (4) in which the X-notches are opened and frontal edge sections (XR) are separated. The sections (27) of glass panes (1) thus obtained are turned through 90 DEG  about the axis perpendicular to the supporting surface (25) in a turning station (5). The Y notches are broken in another breaking station (8). After any edge strips (XR) and residual pieces (R) have been removed, the sections thus obtained are inserted directly into a device (12) for their intermediate storage or fed to a double-glazing line.
Patent AU-4593389-A (AU)
Title: Ambient temperature curing polymer compositions
Inventor: SAY TERENCE E
IPC: C08F220/28
Filed: 1989-12-05
Abstract: The invention relates to a coating composition which cures at ambient temperatures which comprises an aqueous dispersion having a pH of 8.5 to 10 of a copolymer of a) acetoacetoxyethyl acrylate or methacrylate, b) glycidyl acrylate or methacrylate, c) an ethylenically unsaturated polymerisable acid, and d) a monomer other than a), b) and c) and copolymerisable therewith, wherein the weight ratio a) to b) is less than or equal to 0.5/l or greater than 1.5/l and the weight ratio of b) to c) is greater than 1.5/l, the total weight percent of a), b) and c) in the copolymer is from 8 to 60, the weight percent of c) is from 1.5 to 20 and the weight percent of d) is from 40 to 92.
Patent AU-4664296-A (AU)
Title: Playing device system
Inventor: EIBA PETER
IPC: G07F17/32
Filed: 1996-01-25
Abstract: PCT No. PCT/EP96/00306 Sec. 371 Date Jul. 25, 1997 Sec. 102(e) Date Jul. 25, 1997 PCT Filed Jan. 25, 1996 PCT Pub. No. WO96/23289 PCT Pub. Date Aug. 1, 1996A playing device system can be used by a number of players with various playing devices at a distance from each other. Each of these devices can be connected to a common host computer via a remote data transmission system and they are controlled by a random symbol generator which determines a winning combination of symbols. In order to simplify the system, the symbol generator is assigned to the host computer, with the playing devices constituting a display indicating the winning combination of symbols generated by the random symbol generator and connected with an input device to participate in the continuous determination of the winnings.
Patent AU-4913200-A (AU)
Title: Method for producing block copolymers
Inventor: BRINKMANN-RENGEL SUZANNE
IPC: C08L53/02
Filed: 2000-04-18
Abstract: The invention relates to a method for the production of a rubber-elastic block copolymer comprising at least one block A consisting of vinyl aromatic monomers and forming a hard phase and/or at least one block B consisting of diene monomers forming a rubber-elastic soft phase and at least one block B/A consisting of vinyl aromatic monomers and diene monomers and forming an (optionally additional) rubber-elastic soft phase, wherein the glass transition temperature Tg of block A is preferably higher than 25 DEG  C and that of block B/A is less than 25 DEG  C, wherein the monomers are polymerized using at least one radical polymerization initiator.
Patent AU-4966699-A (AU)
Title: Formaldehyde dehydrogenase genes from methylotrophic yeasts
Inventor: CREGG JAMES M
IPC: C12N9/02
Filed: 1999-07-02
Abstract: The present invention provides formaldehyde dehydrogenase genes (FLD) from methylotrophic yeasts. The FLD structural genes confer resistance to formaldehyde and are therefore useful as a selectable marker in methylotrophic yeasts. The FLD promoter sequences are strongly and independently induced by either methanol as sole carbon source (with ammonium sulfate as nitrogen source) or methylamine as sole nitrogen source (with glucose as carbon source). Induction under either methanol, methylamine or both provides levels of heterologous gene expression comparable to those obtained with the commonly used alcohol oxidase I gene promoter (P?AOX1?). The FLD promoter of Pichia pastoris (P?FLD1?) is an attractive alternative to P?AOX1? for expression of foreign genes in P. pastoris, allowing regulation by carbon (methanol) or nitrogen (methylamine) source within the same expression strain. Yeast strains, expression cassettes, expression vectors, and host cells comprising an FLD gene promoter and 3' termination sequence are also provided.
Patent AU-5089698-A (AU)
Title: Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
Inventor: BROWNING JEFFREY
IPC: A61K39/395
Filed: 1997-10-24
Abstract: Compositions and methods comprising "lymphotoxin- beta  receptor blocking agents" which block lymphotoxin-ss receptor signalling and are useful for altering immunological diseases, and particularly antibody mediated immune responses.
Patent AU-5092685-A (AU)
Title: A preparation for the treatment of hemophilia a inhibitor patients and a process for producing such a preparation
Inventor: OLE NORDFANG
IPC: C07K14/755
Filed: 1985-11-05
Abstract: PCT No. PCT/DK85/00105 Sec. 371 Date Jun. 20, 1986 Sec. 102(e) Date Jun. 20, 1986 PCT Filed Nov. 5, 1985 PCT Pub. No. WO86/02838 PCT Pub. Date May 22, 1986.A preparation for the treatment of hemophilia A inhibitor patients contains a protein or peptide having a specific Factor VIII:CAg activity of at least 0.5, preferably at least 1 VIII:CAg unit per mg protein, the ratio between the VIII:CAg activity and the VIII:C procoagulant activity being greater than 5:1, preferably greater than 10:1. A fragment of Factor VI-II:C, which displays a doublet of a molecular weight of 80/77 kD in electrophoresis, is reactive hemophilia A inhibitor antibodies and has VIII:CAg activity. This fragment and more low-molecular fragments of Factor VIII:C are capable of neutralizing the coagulation inhibiting effect of all tested antibodies. Such fragments can therefore be used as active component in preparations for providing immunotolerance towards Factor VIII:C in high-dose treatment of inhibitor patients. The peptides are moreover useful as an immunosorbent in specific extracorporeal adsorption treatment of inhibitor patients. The inhibitor reactive peptides can e.g. be recovered from plasma fractions by affinity chromatography, hydrophobic interaction chromatography or cation exchange or they may be biosynthetically and recovered in a similar manner.
Patent AU-5634596-A (AU)
Title: Recombinant vesiculoviruses and their uses
Inventor: ROSE JOHN K
IPC: C07K14/145
Filed: 1996-05-01
Abstract: The invention provides recombinant replicable vesiculoviruses. The invention provides a method which, for the first time, successfully allows the production and recovery of replicable vesiculoviruses, as well as recombinant replicable vesiculoviruses, from cloned DNA, by a method comprising expression of the full-length positive-strand vesiculovirus antigenomic RNA in host cells. The recombinant vesiculoviruses do not cause serious pathology in humans, can be obtained in high titers, and have use as vaccines. The recombinant vesiculoviruses can also be inactivated for use as killed vaccines.
Patent AU-5690290-A (AU)
Title: Leukotriene antagonists
Inventor: FRAZEE JAMES SIMPSON
IPC: C07C323/66
Filed: 1990-06-08
Abstract: Compounds represented by the following structural formula (I): <CHEM>  wherein q is O or 2;  R1 is (L)a-(CH2)b-(T)c-M  a is 0 or 1;  b is 3 to 14;  c is 0 or 1;  L and T are independently oxygen or CH2; M is C1-4 alkyl, ethynyl, trifluoromethyl, isopropenyl, furanyl, thienyl, cyclohexyl or phenyl optionally monosubstituted with Br, Cl, CF3, alkoxy, alkyl, methylthio, or trifluoromethylthio;    Y is (CHX)(CH2)p-Z wherein  Z is COR3, or tetrazolyl; in which  R3 is OH, NH2, aryloxy, or C1-6 alkoxy;  p is 0, 1 or 2;  X is OH, or alkoxy;  R is -(CH2)p-W;  d is 0 to 6;  W is phenyl substituted with B, C, or D; B is-(CH2)p-V wherein p is 0 to 6 and V is COR3, SO3H, SO2H, SO2NH2, COCH2OH, CHOHCH2OH, or tetrazolyl, with R3 as defined above; C and D are independently selected from H, OH, F, Cl, Br, CF3, alkyl, alkoxy, methylthio, trifluoromethylthio, NO2, NH2, NHalkyl, or CalkylCO-; or pharmaceutically acceptable salts thereof, can be used in the preparation of a medicament for the treatment of asthma.
Patent AU-5711490-A (AU)
Title: Polymeric polyalkyl-1-oxa-diazaspirodecanes
Inventor: SCHMAILZL GEORG
IPC: C08G73/06
Filed: 1990-06-15
Abstract: Novel polymeric polyalkyl-1-oxa-diazaspirodecanes of the formula I <IMAGE> (I)  are very effective stabilizers for natural any synthetic polymers. They have very low volatility, high migration resistance and high thermal stability.
Patent AU-5836986-A (AU)
Title: Regimen for treating osteoporosis
Inventor: FLORA LAWRENCE
IPC: A61P19/10
Filed: 1986-06-05
Abstract: Amethodfortreating or preventing osteoporosis utilizing a cyclic regimen comprising alternating for two or more cyclesthe administration of a bone resorption inhibiting polyphosphonate and a no treatment (rest) period. Further disclosed is a kit for use in implementing this method of treatment.
Patent AU-5858486-A (AU)
Title: Electrochemical cell sensor for continuous, short-term use in tissues and blood
Inventor: GOUGH DAVID A
IPC: A61B5/00
Filed: 1986-06-12
Abstract: An electrochemical cell sensor for monitoring oxidizable enzyme substrates in biological fluids situated in a housing and suitable for implantation in the body, including at least one oxygen or hydrogen peroxide sensing electrode containing a suitable oxidase enzyme, a reference electrode, and a counter electrode all in communication with biological fluids through one or more openings in the walls of the housing.
Patent AU-5935894-A (AU)
Title: Prostatic stent
Inventor: MIKULICH MICHAEL
IPC: A61F2/04
Filed: 1994-04-08
Abstract: A prostatic stent having an elongate body (13) defining a passage therethrough and comprising a distal section (17), a mid-section (19) and a proximal section (21), said elongate body (13) having a length sufficient to extend distally from a bladder neck (3) to a position somewhat short of the external sphincter (9), and said proximal section (21) having a shape conforming to the neck (3) of the urinary bladder (1); and processes for the manufacture of such prostatic stent of a metallic braided type. <IMAGE>
Patent AU-6152990-A (AU)
Title: Cyclodextrin polymer beads
Inventor: VANZO EDWARD
IPC: C09K23/52
Filed: 1990-08-07
Abstract: The process entails forming a droplet of water, cyclodextrin and base in a non-polar solvent such as methylisobutylketone using polyvinyl butyral as an emulsifier. A cross-linking agent such as epichlorohydrin is reacted with the cyclodextrin and emulsifying agent to form the spherical polymer bead.
Patent AU-6184101-A (AU)
Title: Coated nanoparticles
Inventor: TAN WEIHONG
IPC: G01N33/552
Filed: 2001-05-14
Abstract: The invention relates to a plurality of nanoparticles having a mean size of between 2 nm and 100 nm, each of said nanoparticles comprising a core comprising a metal; and a silica shell enveloping the core. The metal is selected from the group consisting of Ag and Cd.
Patent AU-6214100-A (AU)
Title: Cork extractor
Inventor: GELBARD MARTIN K
IPC: B67B7/10
Filed: 2000-07-12
Abstract: An extractor for removing a cork from the inside of a main body of a narrow neck bottle comprises a handle, and at least two generally oval wire loops depending from the handle, the wire loops being deformable so they can fit through the neck and expand and capture a cork. Optionally mesh is provided with the loops for extracting cork fragments. The mesh can be held in place by interlocking the loops together.
Patent AU-6248090-A (AU)
Title: Beacon carrier
Inventor: AKERBERG DAG E SON
IPC: H04W48/16
Filed: 1990-09-12
Abstract: In a cellular mobile radio system a method of choosing at a mobile station an appropriate base station and time slot on a time division multiplexed radio channel for the purpose of call set up or handover, wherein each base station transmits in one time slot of a predetermined control radio channel and, at least once during a multiframe, in each communication radio channel time slot used by the base station for calls, roaming signals comprising information on identity of transmitting base station and communication radio channels available at transmitting base station, the mobile scanning the control and communication channels and when desirous of call set up or handover selecting a base station and a time slot on a communication channel, the mobile desirous of call set up or handover transmitting to the choosen base information on mobile identity and the choosen communication channel time slot.
Patent AU-6257694-A (AU)
Title: Cross-linkable dispersion powder useful as binder for fibers
Inventor: KINKEL JOHANNES
IPC: D04H1/60
Filed: 1994-03-03
Abstract: PCT No. PCT/EP94/00625 Sec. 371 Date Aug. 29, 1995 Sec. 102(e) Date Aug. 29, 1995 PCT Filed Mar. 3, 1994 PCT Pub. No. WO94/20661 PCT Pub. Date Sep. 15, 1994This invention covers the use of cross-linkable redispersible dispersion powders based on vinyl ester copolymers or (meth)acrylic acid ester copolymers as binders for the dry binding of fibre materials.
Patent AU-6406496-A (AU)
Title: Cd4-derived peptides that inhibit immune responses
Inventor: KORNGOLD ROBERT
IPC: A61K31/00
Filed: 1996-06-28
Abstract: The application concerns a method of identifying compounds that can be used to inhibit undesired human CD4+ T cell immune responses by identifying compounds that block the interaction of CD4 and MHC, class II, gene products and a method of treatment which comprises administering such an identified compound. The compounds that inhibit undesired human CD4+ T cell immune responses can be used to treat disease such as multiple sclerosis and to prevent graft rejection and graft versus host disease. More specifically, the application concerns compounds having molecular weights between about 1400 and 400 that mimic three portions of the human CD4 lymphocyte cell surface antigen. The portions are residues 29-35, the C-C' loop of the D1 domain; residues 317-323, the C-C' loop of the D4 domain; and residues 346-353, the CDR3 or FG ridge of the D4 domain of the CD4 molecule. Specific examples of such compounds include cyclic peptides and peptidomimetic.